<?xml version="1.0" encoding="UTF-8"?>
<p>The vast majority of studies reported CHIKV testing on blood or cerebrospinal fluid (CSF); 
 <xref ref-type="supplementary-material" rid="pone.0207554.s005">S2 Table</xref>. Uncommon samples that were successfully tested for CHIKV included corneas [
 <xref rid="pone.0207554.ref066" ref-type="bibr">66</xref>], oral secretions [
 <xref rid="pone.0207554.ref067" ref-type="bibr">67</xref>–
 <xref rid="pone.0207554.ref069" ref-type="bibr">69</xref>], peritoneal, gastric and blister fluids [
 <xref rid="pone.0207554.ref070" ref-type="bibr">70</xref>–
 <xref rid="pone.0207554.ref073" ref-type="bibr">73</xref>], urine and semen [
 <xref rid="pone.0207554.ref074" ref-type="bibr">74</xref>]. Saliva was found to be useful in molecular testing only for a week post symptom onset and was reported to be less sensitive than blood samples in one study [
 <xref rid="pone.0207554.ref069" ref-type="bibr">69</xref>]. Another study reported identifying viable virus in urine and semen samples even up to 30 days post infection [
 <xref rid="pone.0207554.ref074" ref-type="bibr">74</xref>].
</p>
